Merck, Glenmark Settle With Direct Purchasers In Zetia Case

By Cara Salvatore · April 18, 2023, 2:49 PM EDT

Drug companies Merck and Glenmark Pharmaceuticals have settled a group of direct purchasers' claims that they gouged drug buyers via an anti-competitive 2010 pay-for-delay patent settlement, leaving one fewer group of...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login